A medical oncologist from Tulane University co-led the VISION trial, a study focusing on the use of a specific engineered radioactive molecule used to target…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.